Oncology

Browse venture capital firms focused on Oncology.

Explore VC firms that invest in Oncology. Filter by country and stage to refine results.

7 of 1354 firms
Filters:
Agent Capital favicon
Agent Capital
United States

Agent Capital is a healthcare venture capital firm focused on novel technologies and therapeutics that address unmet patient need.

Founded 2017
Investment Stages
Seed
Series A
Series B
Series C
Markets
Rare Diseases
Oncology
Neurology
Immunology
Artis Ventures favicon
Artis Ventures
United States

Artis Ventures is a venture capital firm focused on investments at the convergence of frontier technologies and medicine. They invest in data-driven life sciences companies creating scalable medical technologies with broad healthcare applications. Their focus is on creating global impact through engineering-first approaches and flexible investment strategies.

Founded 2001
Investment Stages
Seed
Series A
Series B
Markets
Oncology
Immunology
Cardiopulmonary + Metabolic
Multi + Other
Neurology + Mental Health
Aging
Infectious
Women's Health
Synthetic & Computation Biology
Clinical Medicine
Consumer Health
Data & Compute
Internet of TechBio (IoTB)
Hikma Ventures favicon
Hikma Ventures
United Kingdom

Hikma Ventures is the strategic venture capital arm of Hikma Pharmaceuticals, investing in innovative digital health and life sciences companies worldwide. They invest in disruptive technologies and meaningful companies with a diverse leadership team. Their investment mandate is broad, focusing on areas where they see strategic advantages for both Hikma and their portfolio companies.

Founded 2015
Investment Stages
Seed
Series A
Series B
Series C
Markets
Digital Health
Life Sciences
Drugs
Digital Therapeutics
Clinical Trial Innovation
Respiratory
CNS
Oncology
Autoimmune
Chronic Diseases
Jeito Capital favicon
Jeito Capital
France

Jeito Capital is a leading global investment company focused on biopharmaceuticals. They finance and accelerate cutting-edge medical innovation with a patient benefit approach, supporting entrepreneurs through significant capital contributions and expert guidance.

Founded 2018
Investment Stages
Series A
Series B
Markets
Biopharmaceuticals
Oncology
Ophthalmology
Rare Skeletal Diseases
Severe Respiratory Diseases
Fibrosis
Immuno-oncology
Cardiovascular Disease
Immuno-Oncology Therapies
Auto-Immune Diseases
Neuromuscular Diseases
Cell Therapy
Gene Therapy
Sanofi Ventures favicon
Sanofi Ventures
United States, France

Sanofi Ventures is the corporate venture capital arm of Sanofi. They invest in top-tier biotech and digital health companies focusing on improving patient care and transforming healthcare. Their investments span from Seed to Series B and beyond, offering portfolio companies access to Sanofi's expertise.

Founded 2001
Investment Stages
Seed
Series A
Series B
Markets
Biotherapeutic
Digital Health
Rare diseases
Immunology and inflammation
Oncology
Cell and gene therapy
Vaccines
Data science
Syncona favicon
Syncona
United Kingdom, Guernsey

Syncona is a FTSE250 company focused on founding, building, and funding healthcare companies. They aim to deliver transformational treatments for patients in areas of high unmet need, building a diversified portfolio of 20-25 globally leading life science businesses.

Founded 2012
Investment Stages
Series A
Series B
Series C
Markets
Oncology
Ophthalmology
Cell therapy
Gene therapy
Renal
Cardioprotection
Immunology
Rare diseases
Vertex Ventures China favicon
Vertex Ventures China
China, Singapore

Vertex Ventures China is a leading venture capital firm managing over ¥15 billion in assets. It invests in high-growth innovative startups across mainland China, focusing on deep tech, healthcare, and consumer tech. The firm provides funding and value-added services to portfolio companies.

Founded 2008
Investment Stages
Seed
Series A
Series B
Markets
Deep tech
Healthcare
Consumer tech
Innovative medicines
Smart Driving
Robotics
AI
Biopharmaceutical
Vaccines
Women’s underwear and lingerie
Automotive-grade chips
Android app stores
Precision oncology